Cargando…

Retracted: The Mechanism of Xiaoyao San in the Treatment of Ovarian Cancer by Network Pharmacology and the Effect of Stigmasterol on the PI3K/Akt Pathway

Detalles Bibliográficos
Autor principal: Markers, Disease
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10356217/
https://www.ncbi.nlm.nih.gov/pubmed/37476639
http://dx.doi.org/10.1155/2023/9791279
_version_ 1785075216253190144
author Markers, Disease
author_facet Markers, Disease
author_sort Markers, Disease
collection PubMed
description
format Online
Article
Text
id pubmed-10356217
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Hindawi
record_format MEDLINE/PubMed
spelling pubmed-103562172023-07-20 Retracted: The Mechanism of Xiaoyao San in the Treatment of Ovarian Cancer by Network Pharmacology and the Effect of Stigmasterol on the PI3K/Akt Pathway Markers, Disease Dis Markers Retraction Hindawi 2023-07-12 /pmc/articles/PMC10356217/ /pubmed/37476639 http://dx.doi.org/10.1155/2023/9791279 Text en Copyright © 2023 Disease Markers. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Retraction
Markers, Disease
Retracted: The Mechanism of Xiaoyao San in the Treatment of Ovarian Cancer by Network Pharmacology and the Effect of Stigmasterol on the PI3K/Akt Pathway
title Retracted: The Mechanism of Xiaoyao San in the Treatment of Ovarian Cancer by Network Pharmacology and the Effect of Stigmasterol on the PI3K/Akt Pathway
title_full Retracted: The Mechanism of Xiaoyao San in the Treatment of Ovarian Cancer by Network Pharmacology and the Effect of Stigmasterol on the PI3K/Akt Pathway
title_fullStr Retracted: The Mechanism of Xiaoyao San in the Treatment of Ovarian Cancer by Network Pharmacology and the Effect of Stigmasterol on the PI3K/Akt Pathway
title_full_unstemmed Retracted: The Mechanism of Xiaoyao San in the Treatment of Ovarian Cancer by Network Pharmacology and the Effect of Stigmasterol on the PI3K/Akt Pathway
title_short Retracted: The Mechanism of Xiaoyao San in the Treatment of Ovarian Cancer by Network Pharmacology and the Effect of Stigmasterol on the PI3K/Akt Pathway
title_sort retracted: the mechanism of xiaoyao san in the treatment of ovarian cancer by network pharmacology and the effect of stigmasterol on the pi3k/akt pathway
topic Retraction
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10356217/
https://www.ncbi.nlm.nih.gov/pubmed/37476639
http://dx.doi.org/10.1155/2023/9791279
work_keys_str_mv AT markersdisease retractedthemechanismofxiaoyaosaninthetreatmentofovariancancerbynetworkpharmacologyandtheeffectofstigmasterolonthepi3kaktpathway